Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Saved in:
| Title: | Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients. |
|---|---|
| Authors: | Leal CTS; Federal University of Juiz de Fora, Juiz de Fora, Brazil. christianneleal74@gmail.com., Costa LJM; University of Alabama at Birmingham, EUA, Birmingham, AL, USA., Pereira J; São Paulo University, São Paulo, Brazil., Duarte FB; Federal University of Ceará, Fortaleza, Brazil., Tavares RB; Federal University of Juiz de Fora, Juiz de Fora, Brazil., Atalla A; Monte Sinai Hospital, Juiz de Fora, Brazil., Sabioni BS; São José Hospital, Teresópolis, Brazil., Neto AEH; Federal University of Juiz de Fora, Juiz de Fora, Brazil. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2022 Feb; Vol. 57 (2), pp. 309-311. Date of Electronic Publication: 2021 Nov 29. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1476-5365 |
|---|---|
| DOI: | 10.1038/s41409-021-01531-3 |
